Beth Hall

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Beth Hall @Bunt1207]

@sarahchapman369 @NEcoastHT Any news on your sofa? X

[Lisa barrott @BarrottLisa]

We need to navigate our messaging to acute care when managing SACT patients presenting unwell- if on I-o & pyrexial, should we hold antibiotics? ⁦@UKONSmember⁩ ⁦@NaiClatsNurse⁩ ⁦@philippajj⁩ ⁦@UHSussex⁩

[Dr Vikash Dodhia @DodhiaVikash]

This succinctly sums up the storm we are in. Something is going to have to give @WendyNg_pharm @DrHMShaw @MVCC_Pharm @sanm99 @rebeccaadevine #CHEMO2022

[NENC Provider Collaborative @NENCproviders]

The new regional aseptic hub will future proof our drug supply for the next 20 years and save lots of money for the NHS ⁦#teamwork @STSFTrust⁩ ⁦@NorthumbriaNHS⁩ ⁦@CDDFTNHS⁩ ⁦@Gateshead_NHS⁩ ⁦@NCICNHS⁩ ⁦@NewcastleHosps⁩ ⁦@NTeesHpoolNHSFT⁩

[Beth Hall @Bunt1207]

@KateJoyce85 You'll be fine. Good luck x

[Beth Hall @Bunt1207]

@KateJoyce85 Rippon construction

[County Durham and Darlington NHS Foundation Trust @CDDFTNHS]

Congratulations Helen Hall🏆

Helen works in AMU at University Hospital North Durham and was crowned this year’s winner of the Excellence in Care – Non-Clinical Award in our annual staff Star Awards.

Well done Helen 👏

#TeamCDDFT

[Beth Hall @Bunt1207]

@jaysh160 @NcccOncology Awww lovely photo XXX

[Beth Hall @Bunt1207]

@KateJoyce85 Where do you send it to? X

[Beth Hall @Bunt1207]

@GullKeetje @royalmarsdenNHS This is amazing ... Do you have a digital copy at all? X

[Zoe Collins @ZoeColl39846619]

Love this!! Would be great @NcccOncology

[Beth Hall @Bunt1207]

@PaulaJayne23 Oh don't think I've heard that one .... Tell me more xx

[Dr Rachel Clarke @doctor_oxford]

Boris Johnson may be ending plan B measures, including mandatory face masks, despite 100k new cases of Covid a day.

But my advice as a doctor is to strongly recommend continuing to wear masks in indoor spaces outside home.

To protect ourselves, our loved ones & each other 💙

[UKONS @UKONSmember]

✅SURVEY: Do you know someone who had used the CR-UK Your Cancer Treatment Record?

Please help promote this 4-minute survey to help with any changes needed from the point of view of those who have used it.

Share the link: https://t.co/JnKR7xxMDf

@Coakley167 @BarrottLisa

[Beth Hall @Bunt1207]

@GMcELHT @lyndsayturne1 Well done xx

[Monty Bojangles @MontyBojangles]

#FreebieFriday alert! 🚨 FOLLOW us and RETWEET this post to be in with a chance of #winning our glorious #vegan gift tower. #Veganuary

ENDS midnight on 11.01.22. Ts&Cs apply.

[Beth Hall @Bunt1207]

@KateJoyce85 Box of 6 bottles in costco... £35 ish. We got a box last year x

[Beth Hall @Bunt1207]

@PaulaJayne23 Massive thank you xxx

[Beth Hall @Bunt1207]

@KateJoyce85 Signed up with 10 mins of receiving email... All free UKONS places Gone!! 😭